Skip to main content
. 2019 May 8;14(5):e0216624. doi: 10.1371/journal.pone.0216624

Fig 2. Drug survival rates due to toxic adverse events in adjusted cases.

Fig 2

Adjusted confounders were baseline age, sex, disease duration, concomitant PSL and MTX, starting date and switched number of bDMARDs. ABT = abatacept, ADA = adalimumab, CZP = certolizumab pegol, ETN = etanercept, GLM = golimumab, IFX = infliximab, TCZ = tocilizumab, bDMARDs = biological disease-modifying antirheumatic drugs.